Skip to content

Stock-Based Comp at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58M+41.5%
GLW
CorningGLW
$115M+113%
Revvity logo
RevvityRVTY
$8.72M+12.7%
Danaher logo
DanaherDHR
$58M-4.9%
Mesa Laboratories logo
Mesa LaboratoriesMLAB
$6.79M+116%
Repligen logo
RepligenRGEN
$8.32M+14.4%

Other financials

Income statement

See full
Revenue$11.0B+6.2%
Operating income$1.9B+8.6%
Net income$1.7B+9.6%
EPS (diluted)$4.43+11.3%

Balance sheet

See full
Cash & equivalents$3.3B-21.4%
Total debt$43.2B+16.6%
Total equity$51.9B+5.2%
Total assets$113.28B+14.4%

Cash flow

See full
Operating cash flow$1.2B+64.9%
CapEx$376.0M+3.9%
Free cash flow$816.0M+126%

Valuation

See full
Market cap$187.95B+25.1%
Enterprise value$227.83B+24.5%
P/E27.5×+4.4×
P/S4.3×-0.8×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%-0.2pp
Debt / equity0.8×+0.1×
Current ratio1.5×-0.2×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's stock-based comp?
Thermo Fisher Scientific (TMO) reported stock-based comp of $83M in Q1 2026.
How has Thermo Fisher Scientific's stock-based comp changed year-over-year?
Thermo Fisher Scientific's stock-based comp increased by 10.7% year-over-year, from $75M to $83M.
What is the long-term trend for Thermo Fisher Scientific's stock-based comp?
Over 4 years (2021 to 2025), Thermo Fisher Scientific's stock-based comp has grown at a 7.7% compound annual growth rate (CAGR), from $230M to $310M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.